Long noncoding RNAs and metabolic memory associated with continued progression of diabetic retinopathy
Journal of Diabetes · 2024-11 · 16 (11)
DOI: 10.1111/1753-0407.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 18.11.2024. Verfasst von Jay Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Diabetic Retinopathy, Disease Progression, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, The Thomas Foundation.
Abstract (Originalsprache)
Progression of diabetic retinopathy resists arrest even after institution of intensive glycemic control, suggesting a “metabolic memory” phenomenon, but the mechanism responsible for this phenomenon is still elusive. Gene expression and biological processes can also be regulated by long noncoding RNAs (LncRNAs), the RNAs with >200 nucleotides and no open reading frame for translation, and several LncRNAs are aberrantly expressed in diabetes. Our aim was to identify retinal LncRNAs that fail to reverse after termination of hyperglycemia. Microarray analysis was performed on retinal RNA from streptozotocin‐induced diabetic rats in poor glycemic control for 8 months, followed by in good glycemic control (blood glucose >400 mg/dL), or for 4 months, with four additional months of good glycemic control (blood glucose 1479 differentially expressed LncRNAs (710 downregulated, 769 upregulated), and among those, 511 common LncRNAs had similar expression in Diab and Rev groups (139 downregulated, 372 upregulated). Gene Ontology/pathway analysis identified limited LncRNAs in biological processes, but analysis based on biological processes/molecular function revealed >350 genes with similar expression in Diab and Rev groups; these genes were mainly associated with stress response, cell death, mitochondrial damage and cytokine production. Thus, identifying retinal LncRNAs and their gene targets that do not benefit from termination of hyperglycemia have potential to serve as therapeutic targets to slow down the progression of diabetic retinopathy. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology, Visual and Anatomical Sciences, Wayne State University, Detroit, Michigan, USA.
ORCID-Profile: Renu A Kowluru
Förderung
- NIH HHS
- NIDDK NIH HHS
- The Thomas Foundation
- NEI NIH HHS
- Research to Prevent Blindness
- National Institutes of Health
Zitieren
APA
Kumar, J., Malaviya, P., & Kowluru, R. A. (2024). Long noncoding RNAs and metabolic memory associated with continued progression of diabetic retinopathy. Journal of Diabetes, 16(11). https://doi.org/10.1111/1753-0407.70009
Vancouver
Kumar J, Malaviya P, Kowluru RA. Long noncoding RNAs and metabolic memory associated with continued progression of diabetic retinopathy. Journal of Diabetes. 2024;16(11). doi:10.1111/1753-0407.70009
BibTeX
@article{Kumar2024,
author = {Kumar, Jay and Malaviya, Pooja and Kowluru, Renu A},
title = {Long noncoding RNAs and metabolic memory associated with continued progression of diabetic retinopathy},
journal = {Journal of Diabetes},
year = {2024},
volume = {16},
number = {11},
doi = {10.1111/1753-0407.70009}
}
EUVIMED